As one of the founders of Leadingpharm, Ms. Gao Shijing, with her profound industry background and outstanding leadership, has led the company to continuous innovation in the highly competitive market, especially achieving remarkable results in the research and development of innovative drugs and improved new drugs. These achievements have not only promoted the company's improvement in product research and development and market expansion, but also set a new benchmark for the pharmaceutical and health field.
 

Mr. Liu Kun, co-founder of Leadingpharm, has more than 30 years of experience in drug research and development and marketing. He has a deep understanding of industry standards and needs, and possesses excellent market insight, providing strong support for the company to seize market opportunities and achieve high-quality development.
 

Mr. Zhang Ronghuo, a member of the IRC Special Committee of the CMAC Central Imaging Alliance and a fourth-phase student of Shell Society, has more than 30 years of experience in clinical research. He has carried out more than 600 clinical trials of various phases (including PhaseⅠ-Ⅳ) covering biological drugs, chemical drugs, traditional Chinese medicines, cell and gene therapy, oncology, rheumatology and immunology, endocrinology, gastroenterology, gynecology, dermatology, nephrology, anti-infection, medical aesthetics, medical devices and other clinical treatment fields. With his outstanding leadership and professional ability, he has promoted new drug research and development and brought significant benefits to patients' health.
 

Mr. Kang Jianlei, former senior reviewer of CDE and doctor of medicinal chemistry from Shenyang Pharmaceutical University, has profound attainments in the field of medicinal chemistry. He is familiar with drug review policies, proficient in the characteristics and technical requirements of pharmaceutical research and development, actively participates in drug research and development practice, promotes the process of drug listing, and has made important contributions to the development of the industry.

The above leaders' awards are not only a recognition of their personal achievements, but also an affirmation of Leadingpharm's contributions to the pharmaceutical and health industry. Their efforts and achievements have not only promoted the company's progress in innovative drug research and development and market expansion, but also set an example for the high-quality development of the entire pharmaceutical industry. Looking forward to the future, Leadingpharm will continue to contribute more to the development of the pharmaceutical and health industry with its innovative spirit and professional strength!
 

-END-